FDA 2026年第二季度与包装相关的召回事件显示,制药和医疗器械领域因泄漏、颗粒物、污染及标签错误风险而出现失效问题。
Siegwerk India head Jatin Takkar warns the packaging industry's focus on recyclability overlooks safety risks from chemi...